PEPTIDE: BPC-157

Most growth factors — EGF, VEGF, and others — are rapidly dismantled by stomach acid and enzymes, requiring sophisticated carrier systems to survive. BPC-157's primary advantage is its inherent stability in acidic environments.

Because the sequence is native to human gastric juice, the body recognizes it as an endogenous signaling agent rather than a foreign chemical. This allows effective oral administration — a potential game-changer for peptides that almost always require injection.

Research confirms it remains stable and active in human gastric juice for more than 24 hours, functioning as a "solo artist" that doesn't require complex delivery systems.

BPC-157 approaches tissue repair through multiple simultaneous pathways:

• FAK-Paxillin Pathway: Activates fibroblast migration and enhances collagen synthesis via Growth Hormone Receptor upregulation on tendon fibroblasts.

• Vascular Regulation: Normalizes the Nitric Oxide system and triggers angiogenesis through the VEGFR2-PI3K-Akt-eNOS axis.

• Neurological Modulation: Acts as a gut-brain axis stabilizer, protecting against CNS disturbances by modulating dopamine and serotonin systems.

• Rapid Gene Activation: Influences gene expression (Nos3, Egr-1, Akt1) within 2-10 minutes of application, activating the self-balancing Egr-1/Nab2 feedback axis.

This Egr-1/Nab2 feedback mechanism is critical — it prevents the harmful tissue overgrowth seen with other growth factors by simultaneously activating proliferation and its co-repressor.